Legend BiotechCorp Correlations
| LEGN Stock | USD 67.31 0.69 1.01% |
The correlation of Legend BiotechCorp is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Legend BiotechCorp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Legend BiotechCorp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend BiotechCorp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.Legend |
The ability to find closely correlated positions to Legend BiotechCorp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Legend BiotechCorp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Legend BiotechCorp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Legend BiotechCorp to buy it.
Moving together with Legend Stock
| + | 0.62 | PFE | Pfizer Inc | Buyout Trend | PairCorr | |
| + | 0.77 | DH | Definitive Healthcare | Fiscal Quarter End 30th of September 2023 | PairCorr | |
| + | 0.62 | COGT | Cogent Biosciences | Fiscal Quarter End 30th of September 2023 | PairCorr | |
| + | 0.79 | TFX | Teleflex Incorporated | Fiscal Quarter End 30th of September 2023 | PairCorr | |
| + | 0.69 | THS | Treehouse Foods | Fiscal Quarter End 30th of September 2023 | PairCorr | |
| + | 0.81 | CPA | Copa Holdings SA | Fiscal Quarter End 30th of September 2023 | PairCorr | |
| + | 0.79 | KO | Coca-Cola | Fiscal Quarter End 30th of September 2023 | PairCorr | |
| + | 0.66 | MCD | McDonalds | Fiscal Quarter End 30th of September 2023 | PairCorr | |
| + | 0.7 | AA | Alcoa Corp | Fiscal Quarter End 30th of September 2023 | PairCorr |
Moving against Legend Stock
| - | 0.66 | XOM | Exxon Mobil Corp | Aggressive Push | PairCorr | |
| - | 0.63 | VII | 7GC Holdings | PairCorr | ||
| - | 0.58 | VSTA | Vasta PlatformLtd | Fiscal Quarter End 30th of September 2023 | PairCorr | |
| - | 0.5 | WEL | Integrated Wellness | PairCorr | ||
| - | 0.5 | CVX | Chevron Corp | Fiscal Quarter End 30th of September 2023 | PairCorr | |
| - | 0.43 | WMT | Walmart | Fiscal Quarter End 31st of October 2023 | PairCorr |
Related Correlations Analysis
EQ | KA | YS | VACC | VALN | VANI | DNTH | ||
EQ | -0.22 | -0.12 | -0.37 | 0.18 | -0.07 | -0.22 | EQ | |
KA | -0.22 | 0.19 | 0.59 | 0.03 | 0.34 | 0.25 | KA | |
YS | -0.12 | 0.19 | 0.21 | 0.82 | 0.8 | -0.67 | YS | |
VACC | -0.37 | 0.59 | 0.21 | -0.02 | 0.4 | 0.0 | VACC | |
VALN | 0.18 | 0.03 | 0.82 | -0.02 | 0.72 | -0.63 | VALN | |
VANI | -0.07 | 0.34 | 0.8 | 0.4 | 0.72 | -0.55 | VANI | |
DNTH | -0.22 | 0.25 | -0.67 | 0.0 | -0.63 | -0.55 | DNTH | |
EQ | KA | YS | VACC | VALN | VANI | DNTH |
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations | High negative correlations |
Risk-Adjusted Indicators
There is a big difference between Legend Stock performing well and Legend BiotechCorp company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Legend BiotechCorp's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Information Ratio | Expected Shortfall | Potential Upside | Value At@Risk | Maximum Drawdown | |
|---|---|---|---|---|---|---|---|---|---|---|
| EQ | 2.35 | 0.07 | 0.03 | (0.19) | 2.51 | 0.0331 | (3.47) | 4.82 | (5.06) | 17.44 |
| KA | 4.34 | 0.52 | 0.11 | 0.29 | 4.11 | 0.09 | (5.61) | 11.38 | (6.76) | 24.40 |
| YS | 3.65 | (0.65) | 0.00 | (0.61) | 0.00 | (0.08) | 0.00 | 3.75 | (9.09) | 70.08 |
| VACC | 3.77 | 0.86 | 0.26 | 0.53 | 2.71 | 0.07 | (5.96) | 4.62 | (5.02) | 98.85 |
| VALN | 2.03 | (0.40) | 0.00 | (0.36) | 0.00 | (0.15) | 0.00 | 3.91 | (4.51) | 14.41 |
| VANI | 2.80 | (0.26) | 0.00 | (0.43) | 0.00 | (0.07) | 0.00 | 5.62 | (7.14) | 16.44 |
| DNTH | 43.90 | 22.68 | 7.44 | 7.15 | 0.00 | 0.12 | (57.27) | 6.85 | (3.61) | 1,474 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Legend BiotechCorp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Legend BiotechCorp Corporate Management
Elected by the shareholders, the Legend BiotechCorp's board of directors comprises two types of representatives: Legend BiotechCorp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Legend. The board's role is to monitor Legend BiotechCorp's management team and ensure that shareholders' interests are well served. Legend BiotechCorp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Legend BiotechCorp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lori CPA | Chief Officer | Profile | |
| Ying Huang | CEO Director | Profile | |
| Yuhong Qiu | VP Affairs | Profile | |
| Guowei Fang | VP Devel | Profile | |
| Alan Kick | VP Quality | Profile | |
| Joanne Choi | Sr Relations | Profile | |
| Steven Gavel | US Devel | Profile |
Already Invested in Legend BiotechCorp?
The danger of trading Legend BiotechCorp is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Legend BiotechCorp is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Legend BiotechCorp. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Legend BiotechCorp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend BiotechCorp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide. Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Legend Stock analysis
When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.16) | Revenue Per Share 0.986 | Quarterly Revenue Growth 5.126 | Return On Assets (0.21) | Return On Equity (0.54) |
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.